Gregory Perry is EVP & CFO at ImmunoGen, Inc. He joined ImmunoGen in January 2009 as Senior Vice President and Chief Financial Officer and was promoted to his current position in March 2011. Before joining ImmunoGen, Mr. Perry was CFO of Elixir Pharmaceuticals, Inc., where he was extensively involved in partnering and fundraising activities.
Hi Louisa, IMO it is a good sign that he is Acquiring and not disposing of shares. I have a feeling that ACT has a lot going on (all good), keeping it to them self for the right time to release the info. I just have this feeling. I hope I am right.
The reason we are stagnant now because the old luggage they have in the trunk…once we get rid of them...we should move north according to plan.